DNA Probes based Diagnostics Market
DNA Probes based Diagnostics Market Analysis by Application (Infectious Diseases, Cancer, Genetic Predisposition, Identity/forensics), by Region - Global Insights to 2030
Analysis of DNA Probes based Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
DNA Probes based Diagnostics Market Insights
DNA probes are stretches of single-stranded DNA, utilized to identify the presence of complementary nucleic acid sequences (target sequences) by hybridization. Marked with a label like color or fluorescence, they allow researchers to detect a distinct sequence of DNA in a mixture. Firstly, the DNA sample is heated to separate the DNA strands after which the probe is applied.
The growing adoption of DNA probes in new disease identification has led to investments and foray of new players. Fact.MR, a global research and consulting firm, in its new report analyzes the DNA probes based diagnostics market in detail, offering comprehensive coverage on the key success factors.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Historical and Future Outlook
DNA probes based technology is being extensively employed in diagnostics as well as in other fields such as micro-fabrication, data handling, molecular biology, instrumentation development, biological sample preparation, and surface chemistry.
As a result, the DNA probes based technology has gained immense popularity in last few years. During the period 2015-2019, DNA probes based diagnostics market has grown at nearly 4%.
Rising public awareness for this technology for prenatal diagnosis and carrier detection is growing rapidly and is expected to result in a significant increase in the demand for such services in the coming years.
Additionally, the rising penetration of automation in diagnosis tests is forecast to create lucrative growth opportunities for the global DNA probes based diagnostics market. During the period 2020-2030, the DNA-probes based diagnostics market is likely to grow at over 5%.
How is Rising Healthcare Spending Supporting Growth?
DNA probes based diagnostics market is presented with a lucrative expansionscope, attributed to burgeoning healthcare expenditure across countries.
The World Health Organization’s Global Spending on Health: Weathering the Storm report revealed that global spending reached US$ 8.3 Tn between 2000 and 2018 representing 10% of global GDP.
Findings reveal that out-of-pocket spending has persisted in low and lower-middle-income economies, representing over 40% of total health spending in 2018. This rising healthcare expenditure is augmenting the demand for DNA probes-based diagnostics.
As countries converge on healthcare, the number of hospitals, clinics, and laboratories is rising.
According to EHealthinsurance, in 2019, there were 6000 hospitals in the US. In 2020, the count reached 6,146, according to the American Hospital Association. This is an aggrandizing demand for DNA probes for various operations.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is the Potential of DNA Probes in New Disease Identification?
W.H.O has declared that, presently, antibiotic resistance is among the biggest threats to global health.
New resistance mechanisms are developing and expanding globally, hampering the ability to treat general infectious diseases. Consequently, DNA probes based diagnostics are gaining immense popularity for their precise detection of these infections.
According to the Review on Antimicrobial Resistance, annual fatalities attributed to antimicrobial resistant infections will rise from the existing 700,000 to 10 million by 2050 unless preventive measures are effectively implemented.
DNA probes, therefore, are proving useful in accurate detection and diagnosis of infectious diseases.
Potential advantages include rapid detection and identification of infectious agents; ability to screen selected specimens using batteries of probes and detection of non-viable or difficult to culture organisms.
Players such as LGC Biosearch Technologies are active players manufacturing various ranges of DNA probes, including BHQplex CoPrimers and BHQplus Probes.
The Opportunity Created by Geriatric Population
Globally, the elderly population is rising due to declining fertility rates increased life expectancy. As people age, they experience several health issues. According to W.H.O, the world's population aged 60 years and older is expected to reach 2 Bn by 2050 which will be a rise from 900 Mn in 2015.
By 2050, 80% of all aged people will reside in low- and middle-income countries. Such predictions are pointing toward several growth opportunities for the DNA probes based diagnostics market. Apart from these, rising disposable income is also fueling the demand for DNA probes based diagnostics.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Challenges for the Market?
While DNA probes have been a welcome development in the global healthcare industry, there are potential associated demerits which are likely to hamper future expansion of the market. In numerous instances, differentiation between species is problematic while using 16S rRNA sequences due to similarity.
The global standard library of rRNA sequences is constantly expanding and continuously being updated, making it difficult to dismiss possibilities of a random hybridization event between a specifically designed probe and an undesired target organism.
Apart from this, recombination between the marker and disease alleles, and incorrect pedigree data or non-paternity leads to erroneous diagnosis. These factors are hampering the growth of the market.
Country-wise Analysis
Why US Remains Key to Growth?
US is an attractive market for DNA probes based diagnostics. High incidence rate of genetic disorders in the country, leading to birth defects, developmental disabilities, and other metabolic syndromes are some of the factors attributable to the growth in the US.
Investments in pharmaceuticals and pharmacogenomics research and development are increasing. According to U.S. Investments in Medical and Health Research and Development, investment in medical and health research and development (R&D) rose by 27% in the five-year period from 2013 to 2017, which was led by industry and the federal government.
The Centers for Disease Control and Prevention (CDC), in the U.S., advocated that about 3% to 4% of newborns were born with genetic abnormalities in 2017.Besides, the rising cancer cases in the country are further increasing the demand for DNA probes based diagnostics.
According to the U.S. National Cancer Institute, in January 2019, there were 16.9 Mn cancer survivors in the U.S. The number of cancer survivors is forecast to reach 22.2 Mn by 2030. Increasing numbers of cancer survivors in the country are thus pointing towards the strengthening of market in the US.
Why is Consolidation in India Key?
India is a lucrative market, forecast to showcase notable growth in forthcoming years. The market in India is growing in terms of revenue generation due to the presence of supportive government initiatives which are leading to an increase in investments by key players and governments.
Increasing prominence of mergers and acquisitions in the healthcare sector are also supporting the growth of the market. According to the India Brand Equity Foundation (IBEF), the value of hospital merger and acquisition (M&A) jumped by a record 155% and reached US$ 1.09 Bn in 2019.
On September 23, 2018, the Government of India started the Pradhan Mantri Jan Arogya Yojana (PMJAY), to give health insurance worth US$ 7,124.54 to more than 100 Mn families every year. With rise population, the number of infectious and other diseases is also rising. Owing to this, the market in India is expected to grow at a significant rate in the coming years.
China to Provide Intense Competition to Global Companies
China is a growing market for DNA probes based market. According to the Centre for Economics and Business Research, China’s economy is about to overtake the U.S’s economy faster than previously in the coming years. As economic growth is inextricably linked with healthcare, an upward trajectory is anticipated in forthcoming years.
Besides, rising initiatives to strengthen healthcare sector is another factor stimulating the demand for DNA probes based diagnostics. In 2016, to handle crowded hospitals in a better way, the government initiated 13th Five-Year Plan (2016-2020) and its Healthy China 2030 strategy.
In April 2018, the State Council also passed guidelines to support internet-based healthcare that encourages medical institutions to promote internet-based technologies.
How is France Emerging as a Lucrative Market?
France is likely to emerge as a highly opportunistic market, chiefly due to rising healthcare expenditure. According to Eurostat, amongst other EU Member States, France had one of the highest healthcare expenditures relative to GDP in 2017.
Increasing incidence of infectious diseases is another reason behind the growth of the market. According to W.H.O, on 13 October 2020, the health authorities of France officially announced 13 laboratory-confirmed cases of Mayaro fever in French Guiana, France, which is likely to create several growth opportunities in coming years.
Besides, rising cases of infection and elderly population shall augment demand for DNA probes based diagnostics. Studies estimate that in the coming decades, the share of the French population that is aged 65 and older will rise steadily and will reach about 25% in 2030 and about 30% in 2050.
What are the Reasons behind the Growth of Market in Germany?
Germany is an attractive market for DNA probes based diagnostics. Eurostat projected the net healthcare expenditure in Germany at US$ 454.01 Bn in 2017, the highest among all European Union Member States.
According Visa Guide World, nearly 19.4 Mn citizens received in-patient treatment in 2017. The total that hospitals spent for in-patient treatments during 2017 was about US$ 112.33 Bn. According to the Federal Statistical Office, this expenditure increased by 3.9% compared to 2016 which was US$ 108.3 Mn. About 30% of healthcare expenditure in Germany is directly given to hospital services. Such activities in the country are support the growth of the market in Germany.
According to an OECD publication, recent reforms in healthcare spending, such as the one on long-term care (LTC) spending has generated white spaces for DNA probes market proliferation. The contribution has increased from 1% of gross income to over 3% presently. Additionally, there is a new evaluation instrument consisting of six modules.
What Prospects abound for the UK Market?
The UK is likely to generate substantial growth opportunities across the 2020-2030 forecast period. According to UK’s Office for National Statistics (ONS), people aged 65 years and over in the UK are projected increase by 8.2 Mn in the next five decades.
Widening healthcare industry of the country is also augmenting the demand for DNA probes based diagnostics in the UK. ONS also stated that, in 2018 government-financed healthcare expenditure increased by 2.0%, while non-government healthcare financing increased by 7.6% due to a rise in out-of-pocket spending.
Apart from these, several government initiatives in the UK are benefitting the market. For instance, it was announced in September 2020 that US$ 39.37 Mn will be funded to develop revolutionary technological approaches to transform healthcare in the UK by 2050.
This initiative promotes ambitious R&D roadmaps and underlines commitment to back incredible scientists and researchers and investment in ground-breaking research to take the UK to the leading position with cutting-edge discoveries.
What is making Italy Emerge Stronger?
Italy is an important market for DNA probes based diagnostics. Its Servizio Sanitario Nazionale offers support to citizens for availing maximum hospital and medical benefits. Healthcare is considered a fundamental right in Italy, with the national health plans accessible to all, including overseas citizens.
Additionally, the World Health Organization ranks the Italian healthcare systems as the 2nd best in the world.
As population growth increases, the burden of genetic, chronic and infectious diseases is also increasing. The Italian National Institute of Statistics estimated a total of over 60 million people as of January 2019. The increase is due to immigration. Total number of foreign nationals grew by 43,480.
Category-wise Insights
Which is the Primary DNA Probes Application Area?
The infectious diseases segment is expected to witness a surge between 2020 and 2030. Growing cases of infectious diseases and the rising elderly population are the key factors behind the growth of this segment.
Apart from this, the cancer segment is also exhibiting significant growth. WHO stated that by 2030 between 10 and 11 Mn cancers will be diagnosed each year in low- and middle-income countries.
Additionally, between 2008 and 2030, the number of new cancer cases is anticipated to rise by more than 80% in low-income countries. Such a rise in cancer cases will directly augment the demand for DNA probes based diagnostics.
Competitive Landscape
With a rising elderly population and growing cases of infectious diseases and cancer, the DNA probes based diagnostics market is getting more competitive. The market is witnessing the entry of several newcomers. Consequently, established players are trying to hold their position by launching innovative products after comprehensive R&D.
For instance, BioMerieux conducted thorough research and developed ARGENE® Solution, which is a comprehensive automated solution devoted to centralized laboratories for the management of molecular biology tests to monitor viral infections in immune-compromised patients. It incorporatespolymerase chain reaction (PCR) technology with real-time NASBA® (Nucleic Acid Sequence-Based Amplification) technology.
Leading market players are also adopting key market strategies such as mergers and acquisitions to strengthen their positions. In 2011, Beckman Coulter was acquired by Danaher, a company that designs and produces medical, industrial, and commercial products and services.
DNA Probes based Diagnostics Market Report: Scope
|
Attribute |
Details |
|---|---|
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2015-2019 |
|
Market Analysis |
US$ Mn for Market Value |
|
Key Countries Covered |
|
|
Key Segments Covered |
Application |
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon Request |
DNA Probes based Diagnostics Market Segmentation by Category
-
By Application :
- Infectious Diseases
- Cancer
- Genetic Predisposition
- Identity/forensics
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the DNA Probes based Diagnostics Market 3.2. Innovation / Development Trends 4. Market Context 4.1. DNA Probes based Diagnostics: Market Evolution 4.2. Key Regulatory Guidelines, By Region 5. Key Success Factors 5.1. Strategic Developments 5.2. Global DNA Probes based Diagnostics Analysis 6. Market Background 6.1. Macro-Economic Factors 6.1.1. Rise in healthcare expenditure 6.1.2. Increasing R&D Expenditure 6.2. Forecast Factors - Relevance & Impact 6.2.1. Technological Advancement 6.2.2. Rising Incidence of Cancer 6.2.3. Growing Geriatric Population and Increase in Healthcare Expenditure 6.2.4. Advent of Novel Methods for High Volume Testing 6.3. Market Dynamics 6.3.1. Drivers 6.3.2. Restraints 6.3.3. Opportunity Analysis 6.4. Market Entry Strategy 7. COVID19 Crisis Analysis 7.1. Current COVID19 Statistics and Probable Future Impact 7.2. Current GDP Projection and Probable Impact 7.3. Current Economic Projection as compared to 2008 financial analysis 7.4. COVID19 and Impact Analysis 7.4.1. Revenue By Application 7.4.2. Revenue By Country 7.5. 2020 Market Scenario 7.6. Quarter by Quarter Forecast 7.7. Projected recovery Quarter 7.8. Recovery Scenario – Short term, Midterm and Long Term Impact 8. Global DNA Probes based Diagnostics Market Value Analysis 2015 – 2019 and Forecast, 2020 – 2030 8.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2019 8.2. Current and Future Market Value (US$ Mn) Projections, 2020 – 2030 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015 – 2019 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2020 – 2030 9.3.1. Infectious Diseases 9.3.2. Cancer 9.3.3. Genetic Predisposition 9.3.4. Identity/forensics 9.3.5. Others 9.4. Market Attractiveness Analysis By Application 10. Global DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 – 2019 10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 – 2030 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 10.5. SWOT Analysis By Region 11. North America DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 11.3. Market Size (US$ Mn)) Forecast By Market Taxonomy, 2020 – 2030 11.3.1. By Country 11.3.1.1. U.S. 11.3.1.2. Canada 11.3.2. By Application 11.4. Market Attractiveness Analysis 11.5. SWOT Analysis 11.6. Key Market Participants - Intensity Mapping 11.7. Drivers and Restraints - Impact Analysis 12. Latin America DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Application 12.4. Market Attractiveness Analysis 12.5. SWOT Analysis 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 13. Europe DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. Italy 13.3.1.3. France 13.3.1.4. U.K. 13.3.1.5. Spain 13.3.1.6. Russia 13.3.1.7. Rest of Europe 13.3.2. By Application 13.4. Market Attractiveness Analysis 13.5. SWOT Analysis 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 14. South Asia DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Indonesia 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Application 14.4. Market Attractiveness Analysis 14.5. SWOT Analysis 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. East Asia DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 15.3. Market Size (US$ Mn Forecast By Market Taxonomy, 2020 – 2030 15.3.1. By Country 15.3.1.1. China 15.3.1.2. Japan 15.3.1.3. South Korea 15.3.1.4. Rest of East Asia 15.3.2. By Application 15.4. Market Attractiveness Analysis 15.5. SWOT Analysis 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Oceania DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Application 16.4. Market Attractiveness Analysis 16.5. SWOT Analysis 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. Middle East and Africa DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020 – 2030 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. South Africa 17.3.1.3. Rest of Middle East and Africa 17.3.2. By Application 17.4. Market Attractiveness Analysis 17.5. SWOT Analysis 17.6. Drivers and Restraints - Impact Analysis 18. Key and Emerging Countries DNA Probes based Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. U.S. DNA Probes based Diagnostics Market Analysis 18.2.1. By Application 18.3. Canada DNA Probes based Diagnostics Market Analysis 18.3.1. By Application 18.4. Mexico DNA Probes based Diagnostics Market Analysis 18.4.1. By Application 18.5. Brazil DNA Probes based Diagnostics Market Analysis 18.5.1. By Application 18.6. U.K. DNA Probes based Diagnostics Market Analysis 18.6.1. By Application 18.7. Germany DNA Probes based Diagnostics Market Analysis 18.7.1. By Application 18.8. France DNA Probes based Diagnostics Market Analysis 18.8.1. By Application 18.9. Italy DNA Probes based Diagnostics Market Analysis 18.9.1. By Application 18.10. Spain DNA Probes based Diagnostics Market Analysis 18.10.1. By Application 18.11. BENELUX DNA Probes based Diagnostics Market Analysis 18.11.1. By Application 18.12. Russia DNA Probes based Diagnostics Market Analysis 18.12.1. By Application 18.13. China DNA Probes based Diagnostics Market Analysis 18.13.1. By Application 18.14. Japan DNA Probes based Diagnostics Market Analysis 18.14.1. By Application 18.15. South Korea DNA Probes based Diagnostics Market Analysis 18.15.1. By Application 18.16. India DNA Probes based Diagnostics Market Analysis 18.16.1. By Application 18.17. ASEAN DNA Probes based Diagnostics Market Analysis 18.17.1. By Application 18.18. Australia DNA Probes based Diagnostics Market Analysis 18.18.1. By Application 18.19. New Zealand DNA Probes based Diagnostics Market Analysis 18.19.1. By Application 18.20. GCC Countries DNA Probes based Diagnostics Market Analysis 18.20.1. By Application 18.21. Turkey DNA Probes based Diagnostics Market Analysis 18.21.1. By Application 18.22. South Africa DNA Probes based Diagnostics Market Analysis 18.22.1. By Application 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product foot print by Players 19.4.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Pricing Analysis by Competition 20.3. Competition Benchmarking 20.4. Competition Deep Dive 20.4.1. Abbott Laboratories 20.4.1.1. Overview 20.4.1.2. Product Portfolio 20.4.1.3. Profitability by Market Segments (Product/Channel/Region) 20.4.1.4. Sales Footprint 20.4.1.5. Strategy Overview 20.4.1.5.1. Marketing Strategy 20.4.1.5.2. Product Strategy 20.4.1.5.3. Channel Strategy 20.4.2. Beckman Coulter Inc 20.4.2.1. Overview 20.4.2.2. Product Portfolio 20.4.2.3. Profitability by Market Segments (Product/Channel/Region) 20.4.2.4. Sales Footprint 20.4.2.5. Strategy Overview 20.4.2.5.1. Marketing Strategy 20.4.2.5.2. Product Strategy 20.4.2.5.3. Channel Strategy 20.4.3. Becton Dickinson & Company 20.4.3.1. Overview 20.4.3.2. Product Portfolio 20.4.3.3. Profitability by Market Segments (Product/Channel/Region) 20.4.3.4. Sales Footprint 20.4.3.5. Strategy Overview 20.4.3.5.1. Marketing Strategy 20.4.3.5.2. Product Strategy 20.4.3.5.3. Channel Strategy 20.4.4. BioMerieux 20.4.4.1. Overview 20.4.4.2. Product Portfolio 20.4.4.3. Profitability by Market Segments (Product/Channel/Region) 20.4.4.4. Sales Footprint 20.4.4.5. Strategy Overview 20.4.4.5.1. Marketing Strategy 20.4.4.5.2. Product Strategy 20.4.4.5.3. Channel Strategy 20.4.5. F Hoffmann-La Roche Ltd 20.4.5.1. Overview 20.4.5.2. Product Portfolio 20.4.5.3. Profitability by Market Segments (Product/Channel/Region) 20.4.5.4. Sales Footprint 20.4.5.5. Strategy Overview 20.4.5.5.1. Marketing Strategy 20.4.5.5.2. Product Strategy 20.4.5.5.3. Channel Strategy 20.4.6. GE Healthcare Life Sciences 20.4.6.1. Overview 20.4.6.2. Product Portfolio 20.4.6.3. Profitability by Market Segments (Product/Channel/Region) 20.4.6.4. Sales Footprint 20.4.6.5. Strategy Overview 20.4.6.5.1. Marketing Strategy 20.4.6.5.2. Product Strategy 20.4.6.5.3. Channel Strategy 20.4.7. Luminex Corporation 20.4.7.1. Overview 20.4.7.2. Product Portfolio 20.4.7.3. Profitability by Market Segments (Product/Channel/Region) 20.4.7.4. Sales Footprint 20.4.7.5. Strategy Overview 20.4.7.5.1. Marketing Strategy 20.4.7.5.2. Product Strategy 20.4.7.5.3. Channel Strategy 20.4.8. Qiagen NV 20.4.8.1. Overview 20.4.8.2. Product Portfolio 20.4.8.3. Profitability by Market Segments (Product/Channel/Region) 20.4.8.4. Sales Footprint 20.4.8.5. Strategy Overview 20.4.8.5.1. Marketing Strategy 20.4.8.5.2. Product Strategy 20.4.8.5.3. Channel Strategy 20.4.9. Siemens Healthineers 20.4.9.1. Overview 20.4.9.2. Product Portfolio 20.4.9.3. Profitability by Market Segments (Product/Channel/Region) 20.4.9.4. Sales Footprint 20.4.9.5. Strategy Overview 20.4.9.5.1. Marketing Strategy 20.4.9.5.2. Product Strategy 20.4.9.5.3. Channel Strategy 20.4.10. Thermofisher Scientific Inc 20.4.10.1. Overview 20.4.10.2. Product Portfolio 20.4.10.3. Profitability by Market Segments (Product/Channel/Region) 20.4.10.4. Sales Footprint 20.4.10.5. Strategy Overview 20.4.10.5.1. Marketing Strategy 20.4.10.5.2. Product Strategy 20.4.10.5.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 02: Global DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 03: North America DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 04: North America DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 05: Latin America DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 06: Latin America DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 07: Europe DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 08: Europe DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 09: South Asia DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 10: South Asia DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 11: East Asia DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 12: East Asia DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 13: Oceania DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 14: Oceania DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
Table 15: Middle East and Africa DNA Probes based Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country
Table 16: Middle East and Africa DNA Probes based Diagnostics Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 02: Global DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 03: Global DNA Probes based Diagnostics Market Absolute $ Opportunity, 2020 - 2030
Figure 04: Global DNA Probes based Diagnostics Market Share Analysis (%), By Application, 2020-2030
Figure 05: Global DNA Probes based Diagnostics Market Y-o-Y Analysis (%), By Application, 2020-2030
Figure 06: Global DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 07: Global DNA Probes based Diagnostics Market Share Analysis (%), By Region, 2020-2030
Figure 08: Global DNA Probes based Diagnostics Market Y-o-Y Analysis (%), By Region, 2020-2030
Figure 09: Global DNA Probes based Diagnostics Market Attractiveness Analysis by Region, 2020-2030
Figure 10: North America DNA Probes based Diagnostics Market Value Share, Application, 2020 (E)
Figure 11: North America DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 12: North America DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 13: North America DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 14: North America DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 15: North America DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 16: Latin America DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 17: Latin America DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 18: Latin America DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 19: Latin America DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 20: Latin America DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 21: Latin America DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 22: Europe DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 23: Europe DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 24: Europe DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 25: Europe DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 26: Europe DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 27: Europe DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 28: South Asia DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 29: South Asia DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 30: South Asia DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 31: South Asia DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 32: South Asia DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 33: South Asia DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 34: East Asia DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 35: East Asia DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 36: East Asia DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 37: East Asia DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 38: East Asia DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 39: East Asia DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 40: Oceania DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 41: Oceania DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 42: Oceania DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 43: Oceania DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 44: Oceania DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 45: Oceania DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 46: Middle East and Africa DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 47: Middle East and Africa DNA Probes based Diagnostics Market Value Share, By Country, 2020 (E)
Figure 48: Middle East and Africa DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2015-2019
Figure 49: Middle East and Africa DNA Probes based Diagnostics Market Value Forecast (US$ Mn), 2020-2030
Figure 50: Middle East and Africa DNA Probes based Diagnostics Market Attractiveness Analysis by Application, 2020-2030
Figure 51: Middle East and Africa DNA Probes based Diagnostics Market Attractiveness Analysis by Country, 2020-2030
Figure 52: U. S. DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 53: U. S. DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 54: Canada DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 55: Canada DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 56: Mexico DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 57: Mexico DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 58: Brazil DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 59: Brazil DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 60: U. K. DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 61: U. K. DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 62: Germany DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 63: Germany DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 64: France DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 65: France DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 66: Italy DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 67: Italy DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 68: Spain DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 69: Spain DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 70: Russia DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 71: Russia DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 72: China DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 73: China DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 74: Japan DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 75: Japan DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 76: South Korea DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 77: South Korea DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 78: India DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 79: India DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 80: ASEAN DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 81: ASEAN DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 82: Australia DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 83: Australia DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 84: New Zealand DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 85: New Zealand DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 86: GCC Countries DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 87: GCC Countries DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 88: Turkey DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 89: Turkey DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Figure 90: South Africa DNA Probes based Diagnostics Market Value Analysis (US$ Mn), 2020 & 2030
Figure 91: South Africa DNA Probes based Diagnostics Market Value Share, By Application, 2020 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are the key trends in the DNA probes based diagnostics market?
Rising healthcare expenditure in the countries, elderly population, and incidences of infectious diseases are augmenting the demand for DNA probes based diagnostics market.
Which are the top companies in the DNA probes based diagnostics market?
Some of the leading companies operating in the DNA probes based diagnostics market are Abbott Laboratories, Beckman Coulter Inc, Becton Dickinson & Company, BioMerieux, F Hoffmann-La Roche Ltd, GE Healthcare Life Sciences, Luminex Corporation, Qiag
What are the key challenges witnessed in the DNA probes based diagnostics market?
The key limitation associated with DNA probes based technology is genetic heterogeneity. This is one of the key challenges for the players operating in the DNA probes based market. Apart from this, recombination between the marker and disease alleles,
Based on Application, Which Segment is Likely to Witness a Surge?
The infectious diseases segment is expected to witness a surge between 2020 and 2030. Growing cases of infectious diseases and the rising elderly population are the key factors behind the growth of this segment.
DNA Probes based Diagnostics Market